A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis

Medicine (United States)

Volumn 95, Issue 47, 2016, Pages

  Ma, Hong ^a   Zeng, Minde ^b   Han, Ying ^c   Yan, Huiping ^d   Tang, Hong ^e   Sheng, Jifang ^f   Hu, Heping ^g   Cheng, Liufang ^h   Xie, Qing ⁱ   Zhu, Youfu ^j   Chen, Guofeng ^k   Gao, Zhiliang ^l   Xie, Wen ^m   Wang, Jiyao ⁿ   Wu, Shanming ^o   Wang, Guiqiang ^p   Miao, Xiaohui ^q   Fu, Xiaoqing ^r   Duan, Liping ^s   Xu, Jie ^t   Wei, Lai ^u   Shi, Guangfeng ^v   Chen, Chengwei ^w   Chen, Minhu ^x   Ning, Qin ^y   Yao, Chen ^p   Jia, Jidong ^a   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e SICHUAN UNIVERSITY   (China)

^f ZHEJIANG UNIVERSITY   (China)

^g SECOND MILITARY MEDICAL UNIVERSITY   (China)

^h CHINESE PLA GENERAL HOSPITAL   (China)

ⁱ SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^j SOUTHERN MEDICAL UNIVERSITY   (China)

^k 302 MILITARY HOSPITAL   (China)

^l THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^m CAPITAL MEDICAL UNIVERSITY   (China)

ⁿ FUDAN UNIVERSITY   (China)

^o Shanghai Public Health Center   (China)

^p PEKING UNIVERSITY FIRST HOSPITAL   (China)

^q SECOND MILITARY MEDICAL UNIVERSITY   (China)

^r Hangzhou Sixth People's Hospital   (China)

^s KUNMING MEDICAL UNIVERSITY   (China)

^t School of Medicine   (China)

^u PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^v FUDAN UNIVERSITY   (China)

^w No 85 Hospital of PLA   (China)

^x SUN YAT SEN UNIVERSITY   (China)

^y HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

more..

Author keywords

Pimary biliary cholangitis; Tauroursodeoxycholic acid; Ursodeoxycholic acid

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID; CHOLAGOGUE; TAUROCHENODEOXYCHOLIC ACID;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHINESE; CHOLANGITIS; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; UNSPECIFIED SIDE EFFECT; ADOLESCENT; AGED; BLOOD; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE; CHINA; CHOLAGOGUES AND CHOLERETICS; CHOLANGITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TAUROCHENODEOXYCHOLIC ACID; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 85005950478     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005391     Document Type: Article

References (19)

1. Beuers U, Maroni L, Elferink RO. The biliary HCO(3)(-) umbrella: experimental evidence revisited. Curr Opin Gastroenterol 2012;28: 253-7.
2. Combes B, Carithers RLJr, Maddrey WC, et al. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1999;29:1649-54.
3. Poupon R. Evidence-based treatment of primary biliary cirrhosis. DigDis 2014;32:626-30.
4. Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 2009;136:1281-7.
5. Shi J, Wu C, Lin Y, et al. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006;101:1529-38.
6. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
7. European Association for the Study of the LEASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51:237-67
8. Larghi A, Crosignani A, Battezzati PM, et al. Ursodeoxycholic and tauroursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Aliment Pharmacol Ther 1997;11:409-14.
9. Rodrigues CMP KB, Steer CJ, Setchell KDR. Tauro-ursodeoxycholic acid is more effective than ursodeoxycholic acid in increasing liver ursodeoxycholate concentration and reducing lithocholate formation in rats. Gastroenterology 1995;109:564-72.
10. Nakai T, Katagiri K, Hoshino M, et al. Microtubule-independent choleresis and anti-cholestatic action of tauroursodeoxycholate in colchicine-treated rat liver. Biochem J 1992;288(Pt 2):613-7.
11. Setchell KD, Rodrigues CM, Podda M, et al. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut 1996;38:439-46.
12. Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 2008;48:871-7.
13. Zhang LN, Shi TY, Shi XH, et al. Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology 2013;58: 264-72.
14. Attili AF, Angelico M, Cantafora A, et al. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986;19:57-69.
15. Heuman DM, Mills AS,McCall J, et al. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991; 100:203-11.
16. Sokol RJ, Straka MS, Dahl R, et al. Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids. Pediatr Res 2001;49:519-31.
17. Invernizzi P, Setchell KD, Crosignani A, et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurineconjugated species in patients with primary biliary cirrhosis. Hepatology 1999;29:320-7.
18. Pan XL, Zhao L, Li L, et al. Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial. JHuazhongUniv Sci TechnologMed Sci 2013;33:189-94.
19. MuracaM, Vilei MT, Cianci V, et al. Effect of tauroursodeoxycholic acid on biliary lipid composition. A dose-response study. Int J Clin Pharmacol Ther 1995;33:391-3.